Publications

5600 Results

Characteristics and Outcomes of Patients with Double-Protein Expression in Limited Stage Diffuse Large B-cell Lymphoma (DLBCL): Interim Analysis of SWOG Study S1001 (NCT01359592)

Authors
DM Stephens;H Li;D Persky;SI Park;N Bartlett;L Swinnen;C Casulo;J Winegarden;L Constine;TJ Fitzgerald;JP Leonard;BS Kahl;M LeBlanc;J Song;L Rimsza;S Smith;JW Friedberg
Journal / Conference
Blood 130:4122; American Society of Hematology Annual Meeting (December 9-12, 2017, Atlanta, GA), poster
Year
2017
Research Committee(s)
Lymphoma
Study Number(s)
S1001

A Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-cell Lymphoma (DLBCL): SWOG Study S1001 (NCT01359592)

Authors
D Perksy;H Li;D Stephens;SI Park;N Bartlett;L Swinnen;P Barr;J Winegarden;L Constine;TJ Fitzgerald;JP Leonard;BS Kahl;M LeBlanc;J Song;L Rimsza;S Smith;J Friedberg
Journal / Conference
Blood 130:1553; American Society of Hematology Annual Meeting (December 9-12, 2017, Atlanta, GA), poster
Year
2017
Research Committee(s)
Lymphoma
Study Number(s)
S1001

An Analysis of Maintenance Therapy and Post-Midostaurin Outcomes in the International Prospective Randomized, Placebo-Controlled, Double-Blind Trial (CALGB 10603/RATIFY [Alliance]) for Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with FLT3 Mutations

Authors
RA Larson;S Mandrekar;B Sanford;K Laumann;S Geyer;C Bloomfield;C Thiede;T Prior;K Dohner;G Marcucci;F Lo-Coco;B Klisovic;A Wei;J Sierra;M Sanz;J Brandwein;T de Witte;D Niederwieser;F Appelbaum;B Medeiros;M Tallman;J Krauter;RF Schlenk;A Ganser;H Serve;G Ehninger;S Amadori;H Dohner;R Stone
Journal / Conference
Blood 130:145; American Society of Hematology Annual Meeting (December 9-12, 2017, Atlanta, GA), oral
Year
2017
Research Committee(s)
Leukemia
Study Number(s)
CTSU/C10603

An Analysis of the Cumulative Incidence of Relapse (CIR) in the International Prospective Randomized, Placebo-Controlled, Double-Blind Trial (CALGB 10603 / RATIFY [Alliance]) for Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with FLT3 Mutations

Authors
R Stone;S Mandrekar;B Sanford;K Laumann;S Geyer;C Bloomfield;K Dohner;C Thiede;G Marcucci;F Lo-Coco;R Klisovic;A Wei;J Sierra;M Sanz;J Brandwein;T de Witte;D Niederwieser;F Appelbaum;B Medeiros;MS Tallman;J Kraute;R Schlenk;A Ganser;H Serve;G Ehninger;S Amadori;H Dohner;R Larson
Journal / Conference
Blood 130:2580; American Society of Hematology Annual Meeting (December 9-12, 2017, Atlanta, GA), poster
Year
2017
Research Committee(s)
Leukemia
Study Number(s)
CTSU/C10603

Prognostic impact of NPM1/FLT3-ITD genotypes from randomized patients treated within the RATIFY CALGB 10603 (Alliance) Study

Authors
K Dohner;S Mandrekar;C Thiede;R Larson;T Prior;G Marcucci;J Krauter;M Heuser;F Lo-Coco;JF Nomdedeu;B Sanford;K Laumann;S Geyer;R Klisovic;A Wei;J Sierra;M Sanz;J Brandwein;T de Witte;D Niederwieser;F Appelbaum;B Medeiros;M Tallman;R Schlenk;A Ganser;H Serve;G Ehninger;S Amadori;Y Cheng;C Pallaud;R Stone;H Dohner;C Bloomfield
Journal / Conference
Blood 130:467; American Society of Hematology Annual Meeting (December 9-12, 2017, Atlanta, GA), oral presentation
Year
2017
Research Committee(s)
Leukemia
Study Number(s)
CTSU/C10603

Associations between Complete Remissions (CRs) with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia and 2-3 Year Survival (“Potential Cure”) Over the Past Four Decades: Analysis SWOG Trial Data

Authors
M Othus;G Garcia-Manero;JE Godwin;J Weick;JE Anderson;DL Stirewalt;F Appelbaum;HP Erba;EH Estey
Journal / Conference
Blood 2017 130:1301; American Society of Hematology Annual Meeting (December 9-12, 2017, Atlanta, GA), poster
Year
2017
Research Committee(s)
Leukemia
Study Number(s)
S0106, S1203, SWOG-8600, SWOG-9031, SWOG-9333

Proteasome inhibitors in cancer therapy [Review]

Authors
E Manasanch;R Orlowski
Journal / Conference
Nature Reviews Clinical Oncology Jul;14(7):417-433, 2017
Year
2017
Research Committee(s)
Myeloma
PMID
PMID28117417
PMC
PMC5828026
Study Number(s)
S0777

Updates on S0820/PACES: Preventing adenomas of the colon with eflornithine and sulindac [Review]

Authors
J Zell;R Krouse;N You
Journal / Conference
Bulletin of the American College of Surgeons October Volume 102, Issue 10, 2017
Year
2017
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0820

Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation

Authors
RM Stone;SJ Mandrekar;BL Sanford;K Laumann;S Geyer;C Bloomfield;C Thiede;T Prior;K Dohner;G Marcucci;F Lo-Coco;RB Klisovic;A Wei;J Sierra;M Sanz;JM Brandwein;T de Witte;D Niederwieser;F Appelbaum;B Medeiros;MS Tallman;J Krauter;R Schlenk;A Ganser;H Serve;G Ehninger;S Amadori;RA Larson;H Dohner
Journal / Conference
New England Journal of Medicine Aug 3;377(5):454-464
Year
2017
Research Committee(s)
Leukemia
PMID
PMID28644114
PMC
PMC5754190
Study Number(s)
CTSU/C10603

Tumor biology and response to chemotherapy impact breast cancer-specific survival in node-positive breast cancer patients treated with neoadjuvant chemotherapy: long-term follow-up from ACOSOG Z1071 (Alliance)

Authors
JC Boughey;KV Ballman;LM McCall;EA Mittendorf;WF Symmans;TB Julian;DR Byrd;KK Hunt
Journal / Conference
Annals of Surgery Oct;266(4):667-676
Year
2017
Research Committee(s)
Breast
PMID
PMID28657941; PMC5755619